ACE and diabetic kidney disease: In the latest Kidney Disease: Improving Global Outcomes guidelines [1], angiotensin-converting enzyme inhibitors (ACEis) and angiotensin-II receptor blockers (ARBs) are recommended for use in DKD patients.